A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions – New IOM Report

Posted on by

JAMA   
June 20, 2012, Vol 307, No. 23
http://jama.ama-assn.org/current.dtl

Viewpoint | June 20, 2012 ONLINE FIRST
A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions – Opportunities Provided by a New IOM Report
Bruce M. Psaty, MD, PhD; Eric M. Meslin, PhD; Alasdair Breckenridge, MD, FRCP
[Free full text: http://jama.jamanetwork.com/article.aspx?articleid=1153777 ]

Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.  Ethical and Scientific Issues in Studying the Safety of Approved Drugs. Washington, DC: National Academies Press; 2012. http://www.iom.edu/Reports/2012/Ethical-and-Scientific-Issues-in-Studying-the-Safety-of-Approved-Drugs.aspx.